[Intravenous immunoglobulins in bone marrow transplantation].
Intravenous immunoglobulins have a role also in the prevention of infections after a bone marrow transplantation. Even if a reduction of CMV pneumonia is reported it is not clear whether such an effect is due to a direct antiviral activity or it is mediated through an immune modulation that reduces GVHD and then the immune suppression. We are currently using i.v.Ig at a dose of 100 mg/kg/day within a protocol for GVHD prophylaxis after a mismatched BMT.
Andolina
M
M
Clinica Pediatrica, Istituto per l'Infanzia Burlo Garofolo di Trieste.
Giorgi
R
R
Maximova
N
N
Comar
M
M
D016026:Bone Marrow Transplantation / Q000009:adverse effects / Q000276:immunology*; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D009503:Neutropenia / Q000276:immunology; D014777:Virus Diseases / Q000517:prevention & control
D016756:Immunoglobulins, Intravenous
Le immunoglobuline endovena nel trapianto di midollo.